EcoDrugPlus

Aldo-Keto Reductase Family 1 Member B

Ensembl ID : ENSCAFG00020023517
Gene Symbol: AKR1B1
2 Cross references
422 Possible Orthologues:

Alpha Glucosidase

Ensembl ID : ENSCAFG00020008231
Gene Symbol: GAA
3 Cross references
233 Possible Orthologues:

Amiloride-Sensitive Amine Oxidase [Copper-Containing]-Like

Ensembl ID : ENSCAFG00020006459
Gene Symbol: LOC112663912
2 Cross references
231 Possible Orthologues:

Amiloride-Sensitive Sodium Channel Subunit Alpha-Like

Ensembl ID : ENSCAFG00020007636
Gene Symbol: LOC112663807
2 Cross references
152 Possible Orthologues:

Amine Oxidase Copper Containing 3

Ensembl ID : ENSCAFG00020013032
Gene Symbol: AOC3
3 Cross references
325 Possible Orthologues:

Amyloid Beta Precursor Protein

Ensembl ID : ENSCAFG00020026329
Gene Symbol: APP
3 Cross references
279 Possible Orthologues:

Androgen Receptor

Ensembl ID : ENSCAFG00020018132
Gene Symbol: AR
3 Cross references
277 Possible Orthologues:

Angiotensin I Converting Enzyme

Ensembl ID : ENSCAFG00020026646
Gene Symbol: ACE
3 Cross references
92 Possible Orthologues:

Angiotensin Ii Receptor Type 1

Ensembl ID : ENSCAFG00020018902
Gene Symbol: AGTR1
3 Cross references
214 Possible Orthologues:

Angiotensin Ii Receptor Type 2

Ensembl ID : ENSCAFG00020004934
Gene Symbol: AGTR2
3 Cross references
195 Possible Orthologues:

Apelin Receptor

Ensembl ID : ENSCAFG00020000452
Gene Symbol: APLNR
3 Cross references
172 Possible Orthologues:

Aph-1 Homolog A, Gamma-Secretase Subunit

Ensembl ID : ENSCAFG00020019671
Gene Symbol: APH1A
3 Cross references
138 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).